The import of cortisone, hydrocortisone, prednisone, and prednisolone to the UK is forecasted to decline sharply from $1.226 million in 2024 to $0.53045 million in 2028. Year-on-year variations reflect significant decreases: approximately 14.62% in 2025, 16.76% in 2026, 19.77% in 2027, and 24.13% in 2028. The compound annual growth rate (CAGR) over the next five years stands at -18.54%, indicating a substantial downward trend in imports.
Future trends to watch for:
- Shifts in domestic production capabilities for these pharmaceuticals.
- Regulatory changes affecting the importation of drugs to the UK.
- Evolving market demands and alternative treatment options.
